Reports on heart failure mortality during the past several years show that it’s on the rise more recently compared to declines, but a research letter released Wednesday in JAMA Cardiology blames the ...

Understanding how patients with heart failure with preserved ejection fraction (HFPEF) die provides insight into the natural history and pathophysiology of this complex syndrome, thereby allowing ...

Both semaglutide and tirzepatide were shown to “significantly reduce” the risk of hospitalization and all-cause mortality for heart failure patients, according to a study published Aug. 31 in JAMA.

The COVID pandemic didn’t just kill people directly. It appears to have accelerated a long-brewing reversal in U.S. heart failure deaths, with mortality climbing faster since 2020 after years of ...

Frailty after kidney transplantation is a harbinger for death and other major adverse outcomes in hospitalized patients. The hospital frailty risk score (HFRS) predicts graft failure, severe infection ...